Publication | Closed Access

Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity

Sézary SyndromeAutoimmune DiseaseImmunodeficienciesT-regulatory CellImmunologyPathologySelf-toleranceAutoimmunityImmunologic DiseaseComplete Molecular RemissionImmunotherapyMedicineCytokine Production